Stephens Reiterates Overweight Rating on Emerson (EMR)
Tweet Send to a Friend
Stephens analyst Rob McCarthy reiterated an Overweight rating and $71.00 price target on Emerson (NYSE: EMR) following a Reuters report ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


